MedTrace Logo

An Observational Study to Examine the Patients With Isolated Systolic Hypertonia (ISH) Under Therapy With Eneas® (NIS ENEAS ISH)

NCT01074281 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2065

Last updated 2014-02-19

No results posted yet for this study

Summary

This non interventional, multicentric, uncontrolled, prospective, observational study was planned to observe the course of disease in subjects with ISH, who were treated with Eneas.

Conditions

Interventions

DRUG

Enalapril maleate (10 mg) + nitrendipine (20 mg)

The drug was administered as per the Summary of Product Characteristics (SPC)

Sponsors & Collaborators

  • Merck KGaA, Darmstadt, Germany

    lead INDUSTRY

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-08-31
Completion
2009-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01074281 on ClinicalTrials.gov